Recombinant multi-species COL5A2 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine COL5A2 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes an alpha chain for one of the low abundance fibrillar collagens. Fibrillar collagen molecules are trimers that can be composed of one or more types of alpha chains. Type V collagen is found in tissues containing type I collagen and appears to regulate the assembly of heterotypic fibers composed of both type I and type V collagen. This gene product is closely related to type XI collagen and it is possible that the collagen chains of types V and XI constitute a single collagen type with tissue-specific chain combinations. Mutations in this gene are associated with Ehlers-Danlos syndrome, types I and II. [provided by RefSeq, Jul 2008]
The Alternative Names of target: 1110014L14Rik,COL5A2,Col5a2,Collagen alpha-2(V) chain,EDSC,EDSCL2
Go
to COL5A2 products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-SE0109-Ag-1/ GM-Tg-hg-SE0109-Ag-2 | Human COL5A2 protein | Human |
| GM-Tg-rg-SE0109-Ag-1/ GM-Tg-rg-SE0109-Ag-2 | Rat COL5A2 protein | Rat |
| GM-Tg-mg-SE0109-Ag-1/ GM-Tg-mg-SE0109-Ag-2 | Mouse COL5A2 protein | Mouse |
| GM-Tg-cynog-SE0109-Ag-1/ GM-Tg-cynog-SE0109-Ag-2 | Cynomolgus/Rhesus macaque COL5A2 protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-SE0109-Ag-1/ GM-Tg-felg-SE0109-Ag-2 | Feline COL5A2 protein | Feline |
| GM-Tg-cang-SE0109-Ag-1/ GM-Tg-cang-SE0109-Ag-2 | Canine COL5A2 protein | Canine |
| GM-Tg-bovg-SE0109-Ag-1/ GM-Tg-bovg-SE0109-Ag-2 | Bovine COL5A2 protein | Bovine |
| GM-Tg-equg-SE0109-Ag-1/ GM-Tg-equg-SE0109-Ag-2 | Equine COL5A2 protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-SE0109-Ag-1/ GM-Tg-hg-SE0109-Ag-2;
GM-Tg-rg-SE0109-Ag-1/ GM-Tg-rg-SE0109-Ag-2;
GM-Tg-mg-SE0109-Ag-1/ GM-Tg-mg-SE0109-Ag-2; GM-Tg-cynog-SE0109-Ag-1/ GM-Tg-cynog-SE0109-Ag-2; GM-Tg-felg-SE0109-Ag-1/ GM-Tg-felg-SE0109-Ag-2; GM-Tg-cang-SE0109-Ag-1/ GM-Tg-cang-SE0109-Ag-2; GM-Tg-bovg-SE0109-Ag-1/ GM-Tg-bovg-SE0109-Ag-2; GM-Tg-equg-SE0109-Ag-1/ GM-Tg-equg-SE0109-Ag-2 |
| Products Name | COL5A2 protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | COL5A2 |
| Protein Sub-location | Secreted Protein/Potential Cytokines |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine COL5A2 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.